The new IFCs are expected to contribute to laboratories performing high sample throughput digital PCR, genotyping and targeted panel testing.
Fluidigm president and chief executive officer Gajus Worthington said the company has introduced the qdPCR 37K IFC to deliver ultra-low cost per sample and accuracy in digital PCR.
”To minimize sample re-work and ambiguous results in high-throughput genotyping, we now offer the High-Precision 96.96 Genotyping IFC,” Worthington added.
”To enable high sample throughput for gene expression applications, we announce the 192.24 Gene Expression IFC.
”Finally, in response to many requests for greater sample and assay flexibility during target selection, we present the FLEXsix™ Gene Expression IFC, first of a family of flexible,configurable IFCs."
With the new IFCs, the BioMark HD system will support the entire span of activity from target selection through production scale-up, without the need for technology-bridging studies.